Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan. | Int J Mol Sci | 2022 | 35806042 | PubTator, text mining | PubMed |
| Endogenous Neural Stem Cell Mediated Oligodendrogenesis in the Adult Mammalian Brain. | Cells | 2022 | 35805185 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Points towards a Multi-Gene Synergistic Action in the Pathogenesis of Congenital Combined Pituitary Hormone Deficiency. | Cells | 2022 | 35805171 | PubTator, text mining | PubMed |
| Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator? | Cancers (Basel) | 2022 | 35805040 | PubTator, text mining | PubMed |
| Obstacles to Glioblastoma Treatment Two Decades after Temozolomide. | Cancers (Basel) | 2022 | 35804976 | PubTator, text mining | PubMed |
| Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma. | Nat Commun | 2022 | 35803925 | PubTator, text mining | PubMed |
| Foxa2 and Pet1 Direct and Indirect Synergy Drive Serotonergic Neuronal Differentiation. | Front Neurosci | 2022 | 35801179 | PubTator, text mining | PubMed |
| Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report. | Open Life Sci | 2022 | 35800072 | PubTator, text mining | PubMed |
| Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset. | Clin Cancer Res | 2022 | 35792876 | PubTator, text mining | PubMed |
| Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer. | iScience | 2022 | 35789834 | PubTator, text mining | PubMed |
| ASCL1 regulates super-enhancer-associated miRNAs to define molecular subtypes of small cell lung cancer. | Cancer Sci | 2022 | 35789143 | PubTator, text mining | PubMed |
| Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC. | Front Cell Dev Biol | 2022 | 35784467 | PubTator, text mining | PubMed |
| Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1. | PLoS One | 2022 | 35776705 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications. | Front Genet | 2022 | 35774512 | PubTator, text mining | PubMed |
| An experimental study of the effects of SNPs in the TATA boxes of the GRIN1, ASCL3 and NOS1 genes on interactions with the TATA-binding protein. | Vavilovskii Zhurnal Genet Selektsii | 2022 | 35774364 | PubTator, text mining | PubMed |
| Comparative analysis of dCas9-VP64 variants and multiplexed guide RNAs mediating CRISPR activation. | PLoS One | 2022 | 35763517 | PubTator, text mining | PubMed |
| POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC. | J Thorac Oncol | 2022 | 35760287 | PubTator, text mining | PubMed |
| Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer. | Proc Natl Acad Sci U S A | 2022 | 35759660 | PubTator, text mining | PubMed |
| The Chromatin Landscape Channels DNA Double-Strand Breaks to Distinct Repair Pathways. | Front Cell Dev Biol | 2022 | 35757003 | PubTator, text mining | PubMed |
| Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence. | Cancer Discov | 2022 | 35754340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=59